Paul V. Woolley - Concepedia

Author

Paul V. Woolley

Also Known As

P V Woolley, P Woolley, P. V. Woolley, P. Woolley, P.V. Woolley, PAUL V. WOOLLEY, Paul V Woolley, Paul V. Woolley, Paul Woolley

121

Publications

3.3K

Citations

H-Index

137

Concepts

All Affiliations

Georgetown University Georgetown University Medical Center Cancer Research Center Wayne State University Children's Hospital of Michigan

About

Paul V. Woolley is an author at Georgetown University specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	34	2.2K
2	Health Sciences	6	6	206
3	Natural Sciences	3	3	111
4	Anatomy	3	3	204
5	Education	2	2	30

Paul V. Woolley

Publications

2.7K

Citations

H-Index

Page 1

	Year	Citations
The Modulation of Fluorouracil With Leucovorin in Metastatic Colorectal Carcinoma Nicholas J. Petrelli, Harold O. Douglass, Lemuel Herrera, Journal of Clinical Oncology October 1989Following AppendixGastrointestinal OncologyMedicineMetastatic Colorectal Carcinoma	1990	281
Pharmacokinetics and protein binding of cis-dichlorodiammine platinum (II) administered as a one hour or as a twenty hour infusion John J. Gullo, Charles L. Litterst, Patrick Maguire, Cancer Chemotherapy and Pharmacology BiochemistryTwenty Hour InfusionMedicineProtein BindingPharmacotherapy	1980	193
SIGNIFICANCE OF SKELETAL LESIONS IN INFANTS RESEMBLING THOSE OF TRAUMATIC ORIGIN Paul V. Woolley Journal of the American Medical Association OsteopathyFracture DiagnosticsSkeletal LesionsAnatomyChronic Subdural Hematoma	1955	177
A phase I clinical trial and pharmacokinetic evaluation of liposome-encapsulated doxorubicin. A Rahman, Joseph Treat, Jae Kyung Roh, Journal of Clinical Oncology Cumulative Doxorubicin DosesPharmaceutical ScienceLiposome-encapsulated DoxorubicinPathologyPharmacotherapy	1990	161
Liposomal protection of adriamycin-induced cardiotoxicity in mice. Aquilur Rahman, Andrea Kessler, Newton S. More, PubMed Pharmaceutical SciencePositive LiposomesCardiovascular PharmacologyPharmacotherapyCardiovascular Toxicity	1980	160
5-Fluorouracil, adriamycin, and mitomycin-C (FAM) chemotherapy for advanced adenocarcinoma of the pancreas Frederick P. Smith, Daniel F. Hoth, Bernard Levin, Cancer Surgical OncologyOncologyThirty-nine PatientsPancreatic CancerGastrointestinal Oncology	1980	123
Antitumor Activity of Liposome-Encapsulated Doxorubicin in Advanced Breast Cancer: Phase II Study Joseph Treat, Andrew Greenspan, Deborah Forst, JNCI Journal of the National Cancer Institute	1990	123
5-fluorouracil, adriamycin, and mitomycin-c (fam) combination chemotherapy in the treatment of advanced gastric cancer John S. Macdonald, Paul V. Woolley, Tariyln Smythe, Cancer Surgical OncologyOncologyCombination ChemotherapyGastrointestinal OncologyAdvanced Gastric Cancer	1979	119
Phase II trial of streptozotocin, mitomycin-C and 5-fluorouracil (SMF) in the treatment of advanced pancreatic cancer R. G. Wiggans, Paul V. Woolley, John S. Macdonald, Cancer Surgical OncologyPathologyPharmacotherapyPancreatic CancerGastrointestinal Oncology	1978	111
Binding and circular dichroism data on bilirubin-albumin in the presence of oleate and salicylate Paul V. Woolley, Margaret J. Hunter Archives of Biochemistry and Biophysics Protein ChemistryBiochemistryProtein FoldingConformational StudyCircular Dichroism Data	1970	104

Page 1